Financials Shanghai Sanyou Medical Co., Ltd

Equities

End-of-day quote Shanghai S.E. Other stock markets 05/12/2025			5-day change	1st Jan Change
18.40 ^CNY	+0.93%		-1.66%	+4.20%

10-27	Shanghai Sanyou Medical Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2025	CI
09-23	Sanyou Medical's Spinal Surgery Robot Passes Drug Regulator's Special Review; Shares Down 4%	MT

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net sales ¹	390.4	593.4	648.9	460.7	452.6	567	724	908.5
Change	-	51.97%	9.37%	-29.01%	-1.74%	25.26%	27.69%	25.48%
EBITDA	149.8	229.9	259.7	170.6	83.35	-	-	-
Change	-	53.49%	12.97%	-34.31%	-51.14%	-	-	-
EBIT ¹	130.4	202.9	228.8	117.3	14.75	126.5	185	251
Change	-	55.58%	12.74%	-48.72%	-87.43%	757.61%	46.25%	35.68%
Interest Paid	-	-	-	-	-	-	-	-
Earnings before Tax (EBT) ¹	137	217.3	240	63.8	21.66	142	200.5	266.5
Change	-	58.59%	10.45%	-73.42%	-66.05%	555.57%	41.2%	32.92%
Net income ¹	118.8	186.4	191.9	129.9	11.3	91.5	129	168.5
Change	-	56.92%	2.97%	-32.31%	-91.3%	709.76%	40.98%	30.62%
Announcement Date	02/02/21	21/02/22	21/02/23	23/02/24	27/02/25	-	-	-

¹CNY in Million

Estimates

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net Debt	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Announcement Date	02/02/21	21/02/22	21/02/23	23/02/24	27/02/25	-	-	-

Estimates

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
CAPEX ¹	30.45	91.29	138.2	25.79	37.44	288	272	250
Change	-	199.8%	51.38%	-81.34%	45.19%	669.3%	-5.56%	-8.09%
Free Cash Flow (FCF) ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Announcement Date	02/02/21	21/02/22	21/02/23	23/02/24	27/02/25	-	-	-

¹CNY in Million

Estimates

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026	2027
Profitability
EBITDA Margin (%)	-	38.36%	38.74%	40.01%	37.03%	18.41%	-	-	-
EBIT Margin (%)	-	33.4%	34.2%	35.25%	25.47%	3.26%	22.31%	25.55%	27.63%
EBT Margin (%)	-	35.1%	36.63%	36.99%	13.85%	4.79%	25.04%	27.69%	29.33%
Net margin (%)	-	30.42%	31.41%	29.57%	28.2%	2.5%	16.14%	17.82%	18.55%
FCF margin (%)	-	-	-	-	-	-	-	-	-
FCF / Net Income (%)	-	-	-	-	-	-	-	-	-
Profitability
ROA	-	-	-	-	-	-	-	-	-
ROE	-	17.77%	11.57%	10.84%	4.87%	0.59%	4.1%	5.5%	6.8%
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	-	7.8%	15.39%	21.3%	5.6%	8.27%	50.79%	37.57%	27.52%
CAPEX / EBITDA (%)	-	20.33%	39.72%	53.22%	15.12%	44.92%	-	-	-
CAPEX / FCF (%)	-	-	-	-	-	-	-	-	-
Items per share
Cash flow per share ¹	-	0.26	0.4861	0.5232	0.897	0.0368	0.4367	0.4417	0.6075
Change	-	-	86.96%	7.63%	71.45%	-95.9%	1,088.19%	1.15%	37.55%
Dividend per Share ¹	-	0.1198	0.1253	-	-	-	-	-	-
Change	-	-	4.6%	-	-	-	-	-	-
Book Value Per Share ¹	-	5.145	5.654	6.171	6.408	6.4	6.583	6.858	7.292
Change	-	-	9.91%	9.13%	3.85%	-0.13%	2.86%	4.18%	6.32%
EPS ¹	-	0.4339	0.6267	0.6439	0.3083	0.0417	0.2917	0.4108	0.54
Change	-	-	44.45%	2.75%	-52.12%	-86.49%	599.93%	40.86%	31.44%
Nbr of stocks (in thousands)	-	298,144	298,144	298,144	298,144	298,144	333,462	333,462	333,462
Announcement Date	-	02/02/21	21/02/22	21/02/23	23/02/24	27/02/25	-	-	-